Mavrogenis Stelios, Urban Róbert, Czeizel Andrew E, Acs Nándor
Department of Uro-oncology, National Institute of Oncology, Budapest, Hungary.
Congenit Anom (Kyoto). 2014 May;54(2):110-5. doi: 10.1111/cga.12041.
The birth prevalence of hypospadias increased in Hungary during the last decades, thus the aim of this study was to analyze the possible role of maternal risk factors in the origin of isolated hypospadias (IHS). The incidence/prevalence of acute and chronic maternal diseases with related drug treatments were compared in the mothers of cases with IHS, population controls without defect and malformed controls affected with other isolated abnormalities in the population-based Hungarian Case-Control Surveillance of Congenital Abnormalities including 3038 cases with IHS, 24 814 population male controls without any defects and 11 096 malformed male controls with other isolated defect. Among exposures, prospective medically recorded chronic diseases and medically recorded or retrospective maternal information regarding acute diseases and drug treatments were evaluated in the study groups. Maternal epilepsy due to the treatment of valproate (odds ratio [OR] with 95% confidence interval [CI]: 1.97, 1.07-3.61) and cervical erosion (4.09, 1.84-9.12) were associated with a higher risk of IHS. In addition, there was an association of oral nystatin (1.94, 1.22-3.09), lynestrenol (26.66, 8.69-81.80) and ethynilestradiol (3.51, 1.61-7.67) treatments in the mothers of cases with a higher risk for IHS. In conclusion, maternal cervical erosion, valproate, nystatin, lynestrenol and ethynilestradiol associated with a higher risk for IHS.
在过去几十年中,匈牙利尿道下裂的出生患病率有所上升,因此本研究的目的是分析母亲风险因素在孤立性尿道下裂(IHS)发病中的可能作用。在基于人群的匈牙利先天性异常病例对照监测中,比较了IHS病例母亲、无缺陷的人群对照以及患有其他孤立异常的畸形对照中急性和慢性母亲疾病及其相关药物治疗的发病率/患病率,该监测包括3038例IHS病例、24814名无任何缺陷的男性人群对照和11096名患有其他孤立缺陷的畸形男性对照。在暴露因素中,研究组评估了前瞻性医学记录的慢性疾病以及关于急性疾病和药物治疗的医学记录或回顾性母亲信息。因丙戊酸治疗导致的母亲癫痫(优势比[OR]及95%置信区间[CI]:1.97,1.07 - 3.61)和宫颈糜烂(4.09,1.84 - 9.12)与IHS风险较高相关。此外,病例母亲中口服制霉菌素(1.94,1.22 - 3.09)、炔诺醇(26.66,8.69 - 81.80)和炔雌醇(3.51,1.61 - 7.67)治疗与IHS风险较高有关。总之,母亲宫颈糜烂、丙戊酸、制霉菌素、炔诺醇和炔雌醇与IHS风险较高相关。